Skip to main content
SpringerLink
Log in

Traitement des métastases cérébrales des CBNPC

The treatment of NSCLC brain metastases

  • Mise au Point / Update
  • Published:
Oncologie

Abstract

Brain metastasis is a very common complication of lung cancer. Therapeutic methods include surgery, radiotherapy, and systemic therapies including chemotherapy and molecular therapies. The main question is the most relevant use of these therapies, which is still not determined. It depends on many factors such as the control of the lung disease, the patient’s general state, and the number ofmetastases. As a result, the decision needs a coordinated and multidisciplinary team approach.

Résumé

Les métastases cérébrales sont une complication fréquente des cancers broncho-pulmonaires. L’arsenal thérapeutique à disposition du clinicien comprend la chirurgie, la radiochirurgie, la radiothérapie et les traitements systémiques (la chimiothérapie et thérapeutiques ciblées), mais les séquences thérapeutiques restent à préciser. Les indications thérapeutiques sont très variables et dépendantes du contrôle de la maladie thoracique, de l’état général du patient, du nombre de métastases cérébrales et de la symptomatologie. La décision thérapeutique nécessite toujours une discussion en réunion de concertation pluridisciplinaire.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Références

  1. A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer With Asymptomatic Untreated Brain Metastasis. ClinicalTrials. gov Identifier: NCT00800202. ML21823, 2008-006504-33

  2. Andrews DW, Scott CB, Sperduto PW, et al. (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363: 1665–1672

    Article  PubMed  Google Scholar 

  3. Aoyama H, Shirato H, Tago M, et al. (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295: 2483–2491

    Article  PubMed  CAS  Google Scholar 

  4. Barlesi F, Gervais R, Lena H, et al. (2011) Pemetrexed and cisplatin as first-line chemotherapy for advanced non-small-cell lung cancer (NSCLC) with asymptomatic inoperable brain metastases: a multicenter phase II trial (GFPC 07-01). Ann Oncol 22: 2466–2470

    Article  PubMed  CAS  Google Scholar 

  5. Chang EL, Wefel J, Hess KR, et al. (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial Original Research Article. The Lancet Oncology 10: 1037–1044

    Article  PubMed  Google Scholar 

  6. Edelman MJ, Belani CP, Socinski MA, et al. (2010) Outcomes associated with brain metastases in a three-arm phase III trial of gemcitabine-containing regimens versus paclitaxel plus carboplatin for advanced non-small cell lung cancer. J Thorac Oncol 5: 110–116

    Article  PubMed  Google Scholar 

  7. Gaspar L, Scott C, Rotman M,, et al. (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1;37(4): 745–751

    Article  CAS  Google Scholar 

  8. Gore E, Bae K, Wong S, et al. (2011) Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: Primary analysis of Radiation Therapy Oncology Group Study RTOG 0214. JCO 29: 272–278

    Article  Google Scholar 

  9. Hotta K, Kiura K, Ueoka H, et al. (2004) Effect of gefitinib (’Iressa’, ZD1839) on brain metastases in patients with advance non-small-cell lung cancer. Lung Cancer 46: 255–261

    Article  PubMed  Google Scholar 

  10. Khuntia D, Brown P, Li J, et al. (2006) Whole-brain radiotherapy in the management of brain metastasis. J Clin Oncol Mar 24: 1295–1304

    Article  CAS  Google Scholar 

  11. Kocher M, Soffietti R, Abacioglu U, et al. (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 29: 134–141

    Article  PubMed  Google Scholar 

  12. Kondziolka D, Patel A, Lunsford LK, et al. (1999) Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1;45(2): 427–434

    Article  Google Scholar 

  13. Mehta MP, Rodrigus P, Terhaard CHJ, et al. (2003) Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21: 2529–2536

    Article  PubMed  CAS  Google Scholar 

  14. Motta M, Del Vecchio A, Attuati L, et al. (2011) Gamma Knife Radiosurgery for Treatment of Cerebral Metastases from Non-Small-Cell Lung Cancer. Int J Radiat Oncol Biol Phys 15;81(4): e463–e468

    Article  PubMed  Google Scholar 

  15. Nieder C, Bremnes RM, Andratschke NH (2009) Prognostic scores in patients with brain metastases from non-small cell lung cancer. J Thorac Oncol 4: 1337–1341

    Article  PubMed  Google Scholar 

  16. Patchell R, Tibbs P, Regine W, et al. (1998) Postoperative Radiotherapy in the Treatment of Single Metastases to the Brain A Randomized Trial. JAMA 280: 1485–1489

    Article  PubMed  CAS  Google Scholar 

  17. Patchell RA, Tibbs PA, Walsh JW, et al. (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322: 494–500

    Article  PubMed  CAS  Google Scholar 

  18. Rades D, Evers JN, Veninga T, et al. (2011) shorter-course whole-brain radiotherapy for brain metastases In elderly patients. Int J Radiation oncology biol Phys Nov 15;81(4): e469–e473

    Article  Google Scholar 

  19. Rades D, Kuetera J-D, Veninga T, et al. (2009) Whole brain radiotherapy plus stereotactic radiosurgery (WBRT + SRS) versus surgery plus whole brain radiotherapy (OP + WBRT) for 1–3 brain metastases: Results of a matched pair analysis. European journal of cancer 45: 400–404

    Article  PubMed  Google Scholar 

  20. Robinet G, Thomas P, Breton JL, et al. (2001) Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe francais de pneumo-cancerologie (GFPC) Protocol 95-1. Ann Oncol 12: 59–67

    Article  PubMed  CAS  Google Scholar 

  21. Schellinger PD, Meinck HM, Thron A (1999) Diagnostic Accuracy of MRI Compared to CCT in Patients with Brain Metastases. J Neurooncol 44: 275–281

    Article  PubMed  CAS  Google Scholar 

  22. Schlienger M, Nataf F, Huguet F, et al. (2010) Place de l’irradiation stéréotaxique hypofractionnée dans le traitement des métastases cérébrales. Cancer/Radiothérapie 14: 119–127

    Article  CAS  Google Scholar 

  23. Sills AK (2005) Current treatment approaches to surgery for brain metastases. Neurosurgery 57: S24–S32

    Article  PubMed  Google Scholar 

  24. Socinski MA, Langer CJ, Huang JE, et al. (2009) Safety of bevacizumab in patients with non-small-cell lung cancer and brain metastases. J Clin Oncol 27: 5255–5261

    Article  PubMed  CAS  Google Scholar 

  25. Sun A, Bae K, Gore E, et al. (2011) Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non-Small-Cell Lung Cancer: neurocognitive and quality-of-life analysis. J Clin Oncol 29: 279–286

    Article  PubMed  Google Scholar 

  26. Tsao MN, Lloyd NS, Wong RK, et al. (2005) Supportive Care Guidelines Group of Cancer Care Ontario’s Program in Evidence-based Care. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 31: 256–273

    Article  PubMed  Google Scholar 

  27. Walbert T and Gilbert MR (2009) The role of chemotherapy in the treatment of patients with brain metastases from solid tumors. Int J Clin Oncol 14: 299–306

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unité d’oncologie thoracique, institut de cancérologie et d’hématologie, CHU de Brest, F-29200, Brest, France

    E. Noël-Savina, R. Descourt & G. Robinet

  2. Service de radiothérapie, institut de cancérologie et d’hématologie, CHU de Brest, F-29200, Brest, France

    E. Le Fur

Authors
  1. E. Noël-Savina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Descourt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Le Fur
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Robinet
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Noël-Savina.

About this article

Cite this article

Noël-Savina, E., Descourt, R., Le Fur, E. et al. Traitement des métastases cérébrales des CBNPC. Oncologie 14, 305–309 (2012). https://doi.org/10.1007/s10269-012-2157-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-012-2157-6

Keywords

Mots clés

Search

Navigation